Abstract:Keywords: <ul><li><a href="/keyword/Antimicrobial+Peptides">antimicrobial peptides</a></li><li><a href="/keyword/Appropriate+Formulation">appropriate formulation</a></li><li><a href="/keyword/Chemical+Modification">chemical modification</a></li><li><a href="/keyword/De+Novo+Design">de novo design</a></li><li><a href="/keyword/Lipopeptide">lipopeptide</a></li><li><a href="/keyword/Pegylation">PEGylation</a></li><li><a href="/keyword/Peptidomimetic">peptidomimetic</a></li><li><a href="/keyword/Prodrug">prodrug</a></li><li><a href="/keyword/Protease+Stability">protease stability</a></li><li><a href="/keyword/Unnatural+Amino+Acid">unnatural amino acid</a></li></ul><h2>References</h2><ul class="rlist separator"><li class="references__item">1. Sommer MOA, Munck C, Toft-Kehler RV, Andersson DI. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nat. Rev. Microbiol. 15(11), 689–696 (2017).<a href="/servlet/linkout?suffix=B1&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1038%2Fnrmicro.2017.75">Crossref</a>, <a href="/servlet/linkout?suffix=B1&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=28757648">Medline</a>, <a href="/servlet/linkout?suffix=B1&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC2sXht1CktLzN">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sommer+MOA%2C+Munck+C%2C+Toft-Kehler+RV%2C+Andersson+DI.+Prediction+of+antibiotic+resistance%3A+time+for+a+new+preclinical+paradigm%3F+Nat.+Rev.+Microbiol.+15%2811%29%2C+689%E2%80%93696+%282017%29.">Google Scholar</a></li><li class="references__item">2. Mansour SC, Pena OM, Hancock RE. Host defense peptides: front-line immunomodulators. Trends Immunol. 35(9), 443–450 (2014).<a href="/servlet/linkout?suffix=B2&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1016%2Fj.it.2014.07.004">Crossref</a>, <a href="/servlet/linkout?suffix=B2&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=25113635">Medline</a>, <a href="/servlet/linkout?suffix=B2&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC2cXhtleisb%252FJ">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mansour+SC%2C+Pena+OM%2C+Hancock+RE.+Host+defense+peptides%3A+front-line+immunomodulators.+Trends+Immunol.+35%289%29%2C+443%E2%80%93450+%282014%29.">Google Scholar</a></li><li class="references__item">3. Ghosh C, Sarkar P, Issa R, Haldar J. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol. 27(4), 323–338 (2019).<a href="/servlet/linkout?suffix=B3&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1016%2Fj.tim.2018.12.010">Crossref</a>, <a href="/servlet/linkout?suffix=B3&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=30683453">Medline</a>, <a href="/servlet/linkout?suffix=B3&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC1MXivF2hsw%253D%253D">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ghosh+C%2C+Sarkar+P%2C+Issa+R%2C+Haldar+J.+Alternatives+to+conventional+antibiotics+in+the+era+of+antimicrobial+resistance.+Trends+Microbiol.+27%284%29%2C+323%E2%80%93338+%282019%29.">Google Scholar</a></li><li class="references__item">4. Wang J, Dou X, Song J et al. Antimicrobial peptides: promising alternatives in the post feeding antibiotic era. Med. Res. Rev. 39(3), 831–859 (2019).<a href="/servlet/linkout?suffix=B4&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1002%2Fmed.21542">Crossref</a>, <a href="/servlet/linkout?suffix=B4&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=30353555">Medline</a>, <a href="/servlet/linkout?suffix=B4&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC1MXntlGksbY%-Abstract Truncated-

Challenges in the development of next-generation antibiotics: opportunities of small molecules mimicking mode of action of host-defense peptides

Small Molecular Mimetics of Antimicrobial Peptides As a Promising Therapy to Combat Bacterial Resistance.

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

Self-Assembling Myristoylated Human Α-Defensin 5 As a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection.

Development and challenges of antimicrobial peptide delivery strategies in bacterial therapy: A review

Development and Challenges of Antimicrobial Peptides for Therapeutic Applications

Using chemical synthesis to optimise antimicrobial peptides in the fight against antimicrobial resistance

Modular Design of Membrane-Active Antibiotics: From Macromolecular Antimicrobials to Small Scorpionlike Peptidomimetics

Advances in microbial antimicrobial peptides expression system and transformation strategy

Mechanisms of Action, Biological Characteristics, and Future Prospects: A Review of Antimicrobial Peptides (A Review)

Antimicrobial peptides with protease stability: progress and perspective

Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale

Towards the Development of Synthetic Antibiotics: Designs Inspired by Natural Antimicrobial Peptides

Chemically modified and conjugated antimicrobial peptides against superbugs.

Antimicrobial peptides: Opportunities and challenges in overcoming resistance

Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance

Advancements, challenges and future perspectives on peptide-based drugs: Focus on antimicrobial peptides

Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides

Engineering Approaches for the Development of Antimicrobial Peptide-Based Antibiotics

Advancements in peptide-based antimicrobials: A possible option for emerging drug-resistant infections